About SubjectWell
SubjectWell is a clinical trial patient recruitment and site enablement company that operates the SubjectWell+ platform to connect patients with clinical trials and new treatment options. The company addresses the clinical trial industry's 80% failure rate by providing comprehensive patient recruitment solutions powered by a Patient Network of over 15 million patients, advanced technology, and extensive partner networks. SubjectWell serves sponsors, CROs, clinical trial sites, site networks, and pharmaceutical brand marketers with flexible, tiered solutions ranging from Study Connect for patient recruitment to Brand Connect for commercial patient engagement. The company has completed over 1,500 studies across 15,000+ sites, supporting more than 500,000 patient referrals in 102 countries. SubjectWell's services include Full-Site Support with clinically-trained, multilingual Patient Companions operating across 36 countries in 22 languages, medical records retrieval, patient communication, transportation logistics, and virtual waiting room services. The platform covers over 400 therapeutic areas including rare diseases, oncology, chronic conditions, and vaccine studies. SubjectWell's mission centers on reducing site and patient burden while accelerating enrollment timelines and improving study outcomes through patient-centric recruitment strategies and comprehensive administrative support services.
Clinical Focus
Medical conditions and clinical areas addressed by SubjectWell.
Who It Serves
Milestones & Awards
Recent Milestones
Launch of OneView Portal to transform and streamline patient recruitment. Clariness announced Jim Corrigan as CEO to lead next phase of growth (March 2026).
Key Partnerships
Social & Media
Latest Updates
Company Details
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 42 →
AiCure
AiCure provides H.Code, an AI-powered patient engagement platform for clinical trials that uses computer vision, predictive analytics, and mobile technology to verify medication adherence, reduce dropout rates, and improve trial data quality for pharmaceutical companies, CROs, and clinical sites.
Antidote
Antidote connects patients with clinical trials through precision recruitment services and their Match search engine. They help pharmaceutical sponsors accelerate enrollment while making it easier for patients to find relevant research opportunities.
BEKhealth
BEKhealth transforms structured and unstructured EHR data into clinical intelligence for trial recruitment and real-world evidence. The platform uses AI to match patients to complex trial criteria in minutes and generates longitudinal real-world data across 30M+ patients and 200+ research sites.
BenevolentAI
public · 180 employees
BenevolentAI unites AI and cutting-edge science to discover and develop new medicines, leveraging a knowledge graph and proprietary ontologies.
Biorce
Biorce develops Aika, an explainable AI platform that accelerates clinical trial design, feasibility assessment, and regulatory planning. The platform helps pharmaceutical companies and CROs reduce trial setup time by 90%, prevent costly protocol amendments, and bring treatments to patients faster.
BIOS Health
BIOS Health develops neural interfaces and AI platforms that read and write the body's neural data to understand and correct signals in real-time. The company enables neural digital therapies for chronic diseases through biomarker discovery and personalized dosing optimization.
Castor
Castor provides an integrated eClinical platform for clinical trials and research, offering EDC, eCOA/ePRO, eConsent, and DCT solutions. The company serves biopharma, CROs, medical device companies, and academic researchers across 100+ countries with over 2,500 commercial trials.
Circuit Clinical
Circuit Clinical is an Integrated Research Organization (IRO) that brings clinical trials directly into community healthcare settings. They partner with physicians, health systems, and FQHCs to expand access to clinical research in historically underrepresented communities across the United States.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.